Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2026-03-18 @ 12:59 AM
Study NCT ID:
NCT03637803
Status:
TERMINATED
Last Update Posted:
2023-06-01
First Post:
2018-08-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors
Sponsor:
4D pharma plc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-03
First Submit QC Date:
None
Study First Post Date:
2018-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-30
Last Update Post Date:
2023-06-01
Last Update Post Date Type:
ACTUAL